A Publication for the Practising Medical Specialist, Industry Executive

Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. 

Stay Ahead in Medical Technology

At Medical Device News Magazine, we take pride in delivering high-quality, in-depth news. Our content goes beyond the surface, providing a comprehensive look at the trends, innovations, and breakthroughs that are shaping the future of medical technology.

In addition, we aim to offer a unique perspective on the rapidly evolving healthcare landscape. By following our news, you gain exclusive insights into industry developments, emerging technologies, and regulatory updates that impact medical devices worldwide. At the same time, you become part of a vibrant community of professionals, innovators, and thought leaders who are dedicated to advancing healthcare through cutting-edge solutions.

Furthermore, we encourage you to explore our diverse range of content, from the latest product announcements to in-depth analyses of industry trends. If our vision aligns with your objectives, we also offer opportunities for advertising and collaboration, allowing you to reach a highly engaged audience of medical technology professionals.

Stay informed, stay connected, and join us as we navigate the future of healthcare together.

Medical Device Industry News: Latest Developments, Breakthroughs, and Future Outlook

Clinical Trials

Easytech Reversed® Stemless

FX Solutions, SAS. [FX Shoulder, Inc.] Completes Easytech Reversed® Stemless IDE Enrollment in the USA

“This is not only a major milestone for FX, but for the next generation of stemless shoulder arthroplasty and the way we think about reverse total shoulder arthroplasty. As a small company, we are excited and humbled to lead the way and be the first to complete this historic study that may bring a novel device to the U.S. market which has already seen over 2000 implanted in Europe since 2015,” said Baptiste Martin, CEO of FX Shoulder USA.

NEJM: New Data on COVID-19 Lung Transplants

The analysis of more than 3,000 lung transplants in the U.S. between Aug. 1, 2020, and Sept. 30, 2021, showed that during the pandemic, 7% of the nation’s lung transplants were performed to treat severe, irreversible lung damage caused by COVID-19. More than half of these patients needed ventilators or extracorporeal membrane oxygenation, or ECMO, before their transplant.

Preclinical Study Provides Guidance for Optimizing Safety and Efficacy of Endovascular Hepatic Denervation Devices to Treat Diabetes

“This study leveraged our deep experience in preclinical evaluation of denervation therapies and could not have been performed in a timely manner without the digital morphometry techniques we developed in-house. We remain excited about the potential of neuromodulation technologies and are committed to supporting further innovation in this space,” explained Rami Tzafriri, PhD, lead author and Director of Research and Innovation at CBSET.

Biotechnology News

Our Experts – Byline Articles

Read Their Views & Share With a Colleague or Two!

Executives on the Move

FDA Medical Device Updates

Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding

Market Reports

Advancements In Imaging

Hospitals In the News

Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry

Non-Profit News

Healthcare: Understanding the Business Side of the Industry and Its Implications

Healthcare Careers

Nurses Corner

Health: A Comprehensive Exploration of Wellness, Nutrition, and Overall Well-Being for a Healthier Life

Articles Designed to Inspire and Guide You Toward Achieving Excellence and Success in All Your Endeavors.